| Tretinoin | Approved Investigational Nutraceutical | LINGO2 | 158038 |
downregulated | Tretinoin results in decreased expression of LINGO2 mRNA | 9p21.2-p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | LIX1 | 167410 |
downregulated | Tretinoin results in decreased expression of LIX1 mRNA | 5q15 | |
| Tretinoin | Approved Investigational Nutraceutical | LMBRD1 | 55788 |
upregulated | Tretinoin results in increased expression of LMBRD1 mRNA | 6q13 | |
| Tretinoin | Approved Investigational Nutraceutical | LMNB1 | 4001 |
downregulated | Tretinoin results in decreased expression of LMNB1 mRNA | 5q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | LMO1 | 4004 |
downregulated | Tretinoin results in decreased expression of LMO1 mRNA | 11p15.4 | |
| Tretinoin | Approved Investigational Nutraceutical | LMO2 | 4005 |
downregulated | Tretinoin results in decreased expression of LMO2 mRNA | 11p13 | |
| Tretinoin | Approved Investigational Nutraceutical | LMO2 | 4005 |
upregulated | Tretinoin results in increased expression of LMO2 mRNA | 11p13 | |
| Tretinoin | Approved Investigational Nutraceutical | LMO3 | 55885 |
downregulated | Tretinoin results in decreased expression of LMO3 mRNA | 12p12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LMO4 | 8543 |
downregulated | Tretinoin results in decreased expression of LMO4 mRNA | 1p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LMO7 | 4008 |
downregulated | Tretinoin results in decreased expression of LMO7 mRNA | 13q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | LONRF2 | 164832 |
upregulated | Tretinoin results in increased expression of LONRF2 mRNA | 2q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | LOR | 4014 |
downregulated | Tretinoin results in decreased expression of LOR mRNA | 1q21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LOX | 4015 |
downregulated | Tretinoin results in decreased expression of LOX mRNA | 5q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | LOXL2 | 4017 |
upregulated | Tretinoin results in increased expression of LOXL2 mRNA | 8p21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LPAR1 | 1902 |
downregulated | Tretinoin results in decreased expression of LPAR1 mRNA | 9q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LPAR1 | 1902 |
upregulated | Tretinoin results in increased expression of LPAR1 mRNA | 9q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LPAR2 | 9170 |
downregulated | Tretinoin results in decreased expression of LPAR2 mRNA | 19p12 | |
| Tretinoin | Approved Investigational Nutraceutical | LPAR3 | 23566 |
downregulated | Tretinoin results in decreased expression of LPAR3 mRNA | 1p22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LPAR4 | 2846 |
downregulated | Tretinoin results in decreased expression of LPAR4 mRNA | Xq21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | LPAR6 | 10161 |
upregulated | Tretinoin results in increased expression of LPAR6 mRNA | 13q14.2 | |
| Tretinoin | Approved Investigational Nutraceutical | LPCAT2 | 54947 |
downregulated | Tretinoin results in decreased expression of LPCAT2 mRNA | 16q12.2 | |
| Tretinoin | Approved Investigational Nutraceutical | LPCAT2 | 54947 |
upregulated | Tretinoin results in increased expression of LPCAT2 mRNA | 16q12.2 | |
| Tretinoin | Approved Investigational Nutraceutical | LPGAT1 | 9926 |
upregulated | Tretinoin results in increased expression of LPGAT1 mRNA | 1q32.3 | |
| Tretinoin | Approved Investigational Nutraceutical | LPIN1 | 23175 |
downregulated | Tretinoin results in decreased expression of LPIN1 mRNA | 2p25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | LPL | 4023 |
upregulated | Tretinoin results in increased expression of LPL mRNA | 8p21.3 | |